NLRP3 and obesity due to melanocortin 4 receptor deficiency: Genetic ablation of NLRP3 or inhibition of NLRP3 by MCC950 could relieve high-sugar diet (HSD), HFD or high sugar/fat diet induced obesity, cardiomyocyte apoptosis and inflammation, and improve the antioxidant capacity to ameliorate cardiac injury.